i-SENS, Inc., headquartered in South Korea (KR), is a leading player in the medical device industry, specialising in innovative diabetes management solutions. Founded in 2000, the company has made significant strides in developing advanced blood glucose monitoring systems and related healthcare technologies. With a strong presence in Asia and expanding operations globally, i-SENS is renowned for its unique products, including the i-SENS Glucometer series, which combines accuracy with user-friendly design. The company’s commitment to research and development has positioned it as a trusted name in diabetes care, achieving notable milestones in product innovation and market reach. i-SENS continues to enhance the quality of life for individuals with diabetes, solidifying its reputation as a pioneer in the field of medical diagnostics.
How does i-SENS, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
i-SENS, Inc.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
i-SENS, Inc., headquartered in South Korea (KR), currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. Consequently, there are no recorded emissions in terms of Scope 1, 2, or 3. Additionally, the company has not established any documented reduction targets or climate pledges, which limits the available information on their climate commitments. As of now, i-SENS, Inc. does not inherit emissions data from any parent or related organizations, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) that would provide further insights into their climate strategy. Without specific emissions data or reduction initiatives, it is challenging to assess their overall impact on climate change or their commitment to sustainability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
i-SENS, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
